Ex-Merck VP Says Investors 'Overstate' Omnicare Impact
Attorneys for a former Merck & Co. Inc. vice president accused of lying about study results on Vioxx's heart attack link told a New Jersey federal court Tuesday that, contrary to...To view the full article, register now.
Already a subscriber? Click here to view full article